Cargando…

Serial O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma

PURPOSE: Intracavitary radioimmunotherapy (RIT) offers an effective adjuvant therapeutic approach in patients with malignant gliomas. Since differentiation between recurrence and reactive changes following RIT has a critical impact on patient management, the aim of this study was to analyse the valu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pöpperl, Gabriele, Götz, Claudia, Rachinger, Walter, Schnell, Oliver, Gildehaus, Franz J., Tonn, Joerg C., Tatsch, Klaus
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2006
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1998889/ https://www.ncbi.nlm.nih.gov/pubmed/16550381 http://dx.doi.org/10.1007/s00259-005-0053-7

Ejemplares similares

O-(2-[(18)F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres
por: Filss, Christian P., et al.
Publicado: (2017)

Quantification of O-(2-[(18)F]fluoroethyl)-L-tyrosine kinetics in glioma
por: Koopman, Thomas, et al.
Publicado: (2018)

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[(18)F]-fluoroethyl)-l-tyrosine PET
por: Bauer, Elena K., et al.
Publicado: (2020)

Quantitative parametric maps of O-(2-[(18)F]fluoroethyl)-L-tyrosine kinetics in diffuse glioma
por: Koopman, Thomas, et al.
Publicado: (2019)

Glioma Imaging by O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Diffusion-Weighted MRI and Correlation With Molecular Phenotypes, Validated by PET/MR-Guided Biopsies
por: Cheng, Ye, et al.
Publicado: (2021)

Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
por: Galldiks, Norbert, et al.
Publicado: (2012)

Two Decades of Brain Tumour Imaging with O-(2-[(18)F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience
por: Heinzel, Alexander, et al.
Publicado: (2022)

First clinical experience with fractionated intracavitary radioimmunotherapy using [(177)Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study
por: Roll, Wolfgang, et al.
Publicado: (2023)

Investigation of Cerebral O-(2-[(18)F]Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models
por: Stegmayr, Carina, et al.
Publicado: (2020)

Cost-Effectiveness of [(18)F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma
por: Baguet, Tristan, et al.
Publicado: (2019)

[(18)F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial
por: Koh, Eng-Siew, et al.
Publicado: (2023)

RESOLUTE PET/MRI Attenuation Correction for O-(2-(18)F-fluoroethyl)-L-tyrosine (FET) in Brain Tumor Patients with Metal Implants
por: Ladefoged, Claes N., et al.
Publicado: (2017)

Rapid, efficient, and economical synthesis of PET tracers in a droplet microreactor: application to O-(2-[(18)F]fluoroethyl)-L-tyrosine ([(18)F]FET)
por: Lisova, Ksenia, et al.
Publicado: (2019)

Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma
por: Kebir, Sied, et al.
Publicado: (2016)

Preclinical PET imaging of HIP/PAP using 1'-(18)F-fluoroethyl-β-D-lactose
por: Yao, Shaobo, et al.
Publicado: (2017)

New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma
por: Verhoeven, Jeroen, et al.
Publicado: (2019)

Para-chloro-2-[(18)F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging
por: Silins, Isabella, et al.
Publicado: (2021)

Correlation of (18)F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool
por: Lopez, William Omar Contreras, et al.
Publicado: (2015)

A Fully Automated Radiosynthesis of [(18)F]Fluoroethyl-Diprenorphine on a Single Module by Use of SPE Cartridges for Preparation of High Quality 2-[(18)F]Fluoroethyl Tosylate
por: Schoultz, Bent W., et al.
Publicado: (2013)

Prognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) PET imaging in glioblastoma multiforme
por: Harat, Maciej, et al.
Publicado: (2019)

Role of fluoroethyl tyrosine positron emission tomography-computed tomography scan in differentiating ewing's sarcoma from osteomyelitis
por: Aggarwal, Hitesh, et al.
Publicado: (2019)

Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET
por: Kim, Jin Su
Publicado: (2016)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Radiosynthesis and pharmacokinetics of [(18)F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
por: Yang, Zhaoshuo, et al.
Publicado: (2017)

Detection of Pancreatic Carcinomas by Imaging Lactose-Binding Protein Expression in Peritumoral Pancreas Using [(18)F]Fluoroethyl-Deoxylactose PET/CT
por: Flores, Leo Garcia, et al.
Publicado: (2009)

A pretargeting system for tumor PET imaging and radioimmunotherapy
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, (18)F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors
por: Jaber, Mohammed, et al.
Publicado: (2015)

(18)F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Intracavitary nodule
por: Marchiori, Edson, et al.
Publicado: (2016)

Chelator-Accelerated One-Pot ‘Click’ Labeling of Small Molecule Tracers with 2-[(18)F]Fluoroethyl Azide
por: Galante, Eva, et al.
Publicado: (2013)

A closer look at the synthesis of 2-[(18)F]fluoroethyl tosylate to minimize the formation of volatile side-products
por: Pijeira, Martha Sahylí Ortega, et al.
Publicado: (2022)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
por: Sabanathan, Dhanusha, et al.
Publicado: (2021)

Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
por: Wei, Weijun, et al.
Publicado: (2020)

Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022)

Intracavitary and Endobronchial Tuberculosis
por: Alsumrain, Mohammad, et al.
Publicado: (2011)

Optimization of a Nucleophilic Two-Step Radiosynthesis of 6-O-(2-[(18)F]fluoroethyl)-6-O-desmethyl-diprenorphine ([(18)F]FE-DPN) for PET Imaging of Brain Opioid Receptors
por: Németh, Enikő, et al.
Publicado: (2023)

Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model
por: Song, In Ho, et al.
Publicado: (2017)

Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
por: Buchegger, Franz, et al.
Publicado: (2011)

Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations
por: Spugnini, Enrico P, et al.
Publicado: (2008)

Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study
por: Grana, C, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_2fprn6tbo5nfjeh8d88em3phc3